SCHEMBL194290

SCHEMBL194290

N#Cc1cc(-c2ccccc2)[nH]c1Sc1ccccc1N

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.54
CYP3A4 P08684 1/20 0.54
CYP2C9 P11712 1/20 0.54
CYP2C19 P33261 1/20 0.54
MAP2K1 Q02750 4/20 0.54
MAP2K2 P36507 2/20 0.54
ALDH1A1 P00352 8/20 0.41
KDM4E B2RXH2 7/20 0.41
KMT2A Q03164 4/20 0.41
RXFP1 Q9HBX9 1/20 0.41
MAPT P10636 5/20 0.40
MAPK1 P28482 2/20 0.40
TDP1 Q9NUW8 3/20 0.39
POLB P06746 1/20 0.39
HPGD P15428 3/20 0.39
CYP19A1 P11511 1/20 0.38
ATM Q13315 1/20 0.38
PARP1 P09874 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
GAA P10253 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29815746 1.00 CYP1A2 (0.54) CYP1A2CYP3A4CYP2C9CYP2C19MAP2K1
SCHEMBL193958 0.83 KDM4E (0.41) MAP2K1MAP2K2ALDH1A1KDM4EKMT2A
SCHEMBL29815961 0.83 PGR (0.46) MAP2K1MAP2K2ALDH1A1KDM4EKMT2A
SCHEMBL194369 0.83 PGR (0.46) MAP2K1MAP2K2ALDH1A1KDM4EKMT2A
SCHEMBL29815772 0.83 KDM4E (0.41) MAP2K1MAP2K2ALDH1A1KDM4EKMT2A
SCHEMBL194587 0.80 KDM4E (0.49) CYP1A2CYP3A4CYP2C9CYP2C19MAP2K1
SCHEMBL194441 0.78 ATM (0.50) ALDH1A1KDM4EKMT2ARXFP1MAPT
SCHEMBL193973 0.77 USP7 (0.42) CYP1A2CYP3A4CYP2C9CYP2C19ALDH1A1
SCHEMBL29816147 0.77 USP7 (0.42) CYP1A2CYP3A4CYP2C9CYP2C19ALDH1A1
SCHEMBL194725 0.75 ALDH1A1 (0.54) ALDH1A1KDM4EKMT2ARXFP1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12351553-B2 Process for producing 5-aryl-1H-pyrolle-3-carbonitrile compounds by dehalogenation TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2025-07-08 US disclosed
US-20230088365-A1 PROCESS FOR PRODUCING PYRROLE COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2023-03-23 US disclosed
US-11498898-B2 Process for producing pyrrole compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2022-11-15 US disclosed
CN-114835619-A Process for preparing azole compounds 武田药品工业株式会社 2022-08-02 CN disclosed
EP-3929187-A2 PROCESS FOR PRODUCING PYRROLE COMPOUND Takeda Pharmaceutical Company Limited (JP) 2021-12-29 EP disclosed
EP-3929187-A2 PROCESS FOR PRODUCING PYRROLE COMPOUND Takeda Pharmaceutical Company Limited (JP) 2021-12-29 EP disclosed
US-20210070705-A1 PROCESS FOR PRODUCING PYRROLE COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2021-03-11 US disclosed
US-20210070705-A1 PROCESS FOR PRODUCING PYRROLE COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2021-03-11 US disclosed
US-10844011-B2 Process for producing pyrrole compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2020-11-24 US disclosed
US-10844011-B2 Process for producing pyrrole compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2020-11-24 US disclosed
US-20140303378-A1 PROCESS FOR PRODUCING PYRROLE COMPOUND TAKEDA PHARMACEUTICAL (JP) 2014-10-09 US disclosed
US-8822694-B2 Process for producing pyrrole compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2014-09-02 US disclosed
US-8822694-B2 Process for producing pyrrole compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2014-09-02 US disclosed
US-8822694-B2 Process for producing pyrrole compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2014-09-02 US disclosed
EP-2765130-A2 Process for producing pyrrole compound Takeda Pharmaceutical Company Limited (JP) 2014-08-13 EP disclosed
CN-102421753-A Process for preparing azole compounds TAKEDA PHARMACEUTICAL 2012-04-18 CN disclosed
EP-2402313-A1 PROCESS FOR PRODUCING PYRROLE COMPOUND Takeda Pharmaceutical Company Limited (JP) 2012-01-04 EP disclosed
US-20110306769-A1 PROCESS FOR PRODUCING PYRROLE COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-12-15 US disclosed
US-20110306769-A1 PROCESS FOR PRODUCING PYRROLE COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-12-15 US disclosed
US-20110306769-A1 PROCESS FOR PRODUCING PYRROLE COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-12-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210070705-A1 PROCESS FOR PRODUCING PYRROLE COMPOUND DHPS, STS, HPD CYP1A2 148/4885CYP3A4 8/4885CYP2C9 26/4885
US-12351553-B2 Process for producing 5-aryl-1H-pyrolle-3-carbonitrile compounds by dehalogenation CYP51A1, PAH, HPD CYP1A2 58/4885CYP3A4 6/4885CYP2C9 39/4885
US-20230088365-A1 PROCESS FOR PRODUCING PYRROLE COMPOUND DHPS, STS, HPD CYP1A2 148/4885CYP3A4 8/4885CYP2C9 26/4885
US-11498898-B2 Process for producing pyrrole compound DHPS, STS, HPD CYP1A2 148/4885CYP3A4 8/4885CYP2C9 26/4885
US-20140303378-A1 PROCESS FOR PRODUCING PYRROLE COMPOUND DHPS, STS, HPD CYP1A2 148/4885CYP3A4 8/4885CYP2C9 26/4885
US-10844011-B2 Process for producing pyrrole compound DHPS, STS, HPD CYP1A2 148/4885CYP3A4 8/4885CYP2C9 26/4885
US-20110306769-A1 PROCESS FOR PRODUCING PYRROLE COMPOUND DHPS, STS, HPD CYP1A2 148/4885CYP3A4 8/4885CYP2C9 26/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.